Work

Successful Implementation of Biventricular HeartMate 3 Ventricular Assist Devices as Destination Therapy

Year: 2026
Type: article
Abstract: Left ventricular assist devices (LVADs) have revolutionized the management of end-stage heart disease since their FDA approval as bridge-to-transplant therapy in 1994, followed by destination therapy approval in 2002. These devices have dramatically expanded treatment options and improved survival for patients with advanced heart failure. However, patients with biventricular heart failure who are ineligible for heart transplantation face particularly complex management challenges, with limited long-term mechanical circulatory support options [1].
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,490
OpenAlex ID: W7126089477
FWCI: 6.007
Cites: 6
Cited by: 2
Related to: 10